IL17A and cancer: In poorly differentiated tumors (G3, green dashed line), IL-17A levels remained consistently lower across the range of IL-8 concentrations and showed a steeper, continuous decline as IL-8 increased, indicating an attenuated or dysregulated inflammatory response in these more aggressive cancers.